334 related articles for article (PubMed ID: 24363507)
21. MALT Lymphoma as a Model of Chronic Inflammation-Induced Gastric Tumor Development.
Marcelis L; Tousseyn T; Sagaert X
Curr Top Microbiol Immunol; 2019; 421():77-106. PubMed ID: 31123886
[TBL] [Abstract][Full Text] [Related]
22. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma?
Thiede C; Morgner A; Alpen B; Wündisch T; Herrmann J; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
Gastroenterology; 1997 Dec; 113(6 Suppl):S61-4. PubMed ID: 9394762
[TBL] [Abstract][Full Text] [Related]
23. Gastric lymphomas: genetics and resistance to H. pylori eradication.
Isaacson PG; Du MQ
Verh Dtsch Ges Pathol; 2003; 87():116-22. PubMed ID: 16888902
[TBL] [Abstract][Full Text] [Related]
24. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
25. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
26. [Helicobacter and lymphoma].
Fischbach W
Chirurg; 1998 Mar; 69(3):249-51. PubMed ID: 9576034
[TBL] [Abstract][Full Text] [Related]
27. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
[TBL] [Abstract][Full Text] [Related]
28. Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma.
Wang HP; Zhu YL; Shao W
World J Gastroenterol; 2013 Dec; 19(45):8219-26. PubMed ID: 24363512
[TBL] [Abstract][Full Text] [Related]
29. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.
Morgner A; Miehlke S; Stolte M; Neubauer A; Alpen B; Thiede C; Klann H; Hierlmeier FX; Ell C; Ehninger G; Bayerdörffer E
World J Gastroenterol; 2001 Apr; 7(2):248-53. PubMed ID: 11819769
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Alpen B; Röbbecke J; Wündisch T; Stolte M; Neubauer A
Ann Hematol; 2001; 80 Suppl 3():B106-7. PubMed ID: 11757689
[TBL] [Abstract][Full Text] [Related]
31. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
Nakamura T; Inagaki H; Seto M; Nakamura S
J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
[TBL] [Abstract][Full Text] [Related]
32. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
Ferreri AJ; Govi S; Ponzoni M
Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
[TBL] [Abstract][Full Text] [Related]
34. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
Kim YS; Kim JS; Jung HC; Lee CH; Kim CW; Song IS; Kim CY
J Gastroenterol; 2002 Jan; 37(1):17-22. PubMed ID: 11824795
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
36. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
[TBL] [Abstract][Full Text] [Related]
37. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial.
Thiede C; Wündisch T; Neubauer B; Alpen B; Morgner A; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
Recent Results Cancer Res; 2000; 156():125-33. PubMed ID: 10802872
[TBL] [Abstract][Full Text] [Related]
38. Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma.
D'Elios MM; Amedei A; Manghetti M; Costa F; Baldari CT; Quazi AS; Telford JL; Romagnani S; Del Prete G
Gastroenterology; 1999 Nov; 117(5):1105-12. PubMed ID: 10535873
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience.
Ryu KD; Kim GH; Park SO; Lee KJ; Moon JY; Jeon HK; Baek DH; Lee BE; Song GA
Gut Liver; 2014 Jul; 8(4):408-14. PubMed ID: 25071906
[TBL] [Abstract][Full Text] [Related]
40. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
